Evidence map›Paper›PMID 42590151›Full record

ReviewJournal of clinical medicine2026

Hour-1 Sepsis Bundle: Updated Evidence.

Gennaro De Pascale, Salvatore Lucio Cutuli, Simone Carelli, Irene Cisterna, Pierluigi Del Vecchio, Emanuele Oscar Franchini, Flavia Lucia Grilli, Gianmarco Lombardi, Altea Palladini, Andrea Tagliamonte and 5 more

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Gennaro De PascaleDepartment of Biotechnologies, Intensive Care and Perioperative Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy.ORCID 0000-0002-8255-0676
Salvatore Lucio CutuliDepartment of Biotechnologies, Intensive Care and Perioperative Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy.ORCID 0000-0001-8135-6284
Simone CarelliDepartment of Emergency Sciences, Anaesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.ORCID 0000-0002-0666-8955
Irene CisternaDepartment of Emergency Sciences, Anaesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Pierluigi Del VecchioDepartment of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.ORCID 0000-0003-4421-912X
Emanuele Oscar FranchiniDepartment of Biotechnologies, Intensive Care and Perioperative Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Flavia Lucia GrilliDepartment of Biotechnologies, Intensive Care and Perioperative Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Gianmarco LombardiDepartment of Emergency Sciences, Anaesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Altea PalladiniDepartment of Biotechnologies, Intensive Care and Perioperative Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Andrea TagliamonteDepartment of Biotechnologies, Intensive Care and Perioperative Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Eloisa Sofia TanzarellaDepartment of Emergency Sciences, Anaesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.
Guru TudimellaDepartment of Biotechnologies, Intensive Care and Perioperative Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy.ORCID 0009-0001-6931-4425
Luca MontiniDepartment of Biotechnologies, Intensive Care and Perioperative Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy.
Domenico Luca GriecoDepartment of Biotechnologies, Intensive Care and Perioperative Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy.ORCID 0000-0002-4557-6308
Massimo AntonelliDepartment of Biotechnologies, Intensive Care and Perioperative Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy.ORCID 0000-0003-3007-1670

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis and septic shock remain leading causes of disability, mortality and healthcare utilization worldwide. Increasing evidence has established sepsis as a time-dependent emergency in which delays in diagnosis and treatment are associated with worsening organ dysfunction and increased mortality. To standardize early management, the Surviving Sepsis Campaign (SSC) developed evidence-based care bundles, culminating in the current Hour-1 Bundle, which emphasizes rapid implementation of key diagnostic and therapeutic interventions. This narrative review critically examines the scientific rationale, clinical evidence, implementation challenges, and future perspectives surrounding the SSC Hour-1 Bundle. Lactate remains a valuable marker of illness severity and treatment response, although its interpretation requires consideration of multiple non-hypoperfusion-related mechanisms. Blood cultures represent the microbiological gold standard, while emerging rapid diagnostic technologies are transforming pathogen identification and antimicrobial stewardship. Early effective antimicrobial therapy remains strongly associated with improved outcomes, although balancing prompt treatment with antimicrobial stewardship remains challenging. Fluid resuscitation strategies have evolved from fixed-volume approaches toward individualized assessment of fluid responsiveness and tolerance, whereas early vasopressor initiation is increasingly recognized as complementary to fluid administration. Although observational studies frequently associate bundle adherence with improved outcomes, real-world compliance remains variable and evidence supporting strict one-hour completion targets remains heterogeneous. Future developments are expected to move beyond standardized protocols toward personalized sepsis management integrating rapid diagnostics, immune phenotyping, advanced haemodynamic monitoring, and artificial intelligence-driven clinical decision support. These innovations may enable more precise therapeutic strategies while preserving the fundamental principles of sepsis management, that remain the cornerstone of contemporary sepsis care.

Indexed as

bundlecritical careintensive caresepsisseptic shock

Identifiers

PMID42590151
PMCPMC13466698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.